Literature DB >> 164413

In ovo assay for Marek's disease virus and turkey herpesvirus.

B M LONGENECKER, F Pazderka, H S Stone, J S Gavora, R F Ruth.   

Abstract

Marek's disease virus (MDV) and the turkey herpesvirus (HVT) may be assayed on the chorioallantoic membrane (CAM) of the chicken embryo after intravenous inoculation of chicken embryo fibroblasts (CEF) or chicken blood leukocytes infected with these viruses. Free HVT, MDV associated with Marek's tumor cells, and lymphoblastoid cell lines derived from Marek's tumors, may be assayed in the same way. The intravenous assay is quicker than the yolk sac assay and somewhat more sensitive than in vitro or conventional CAM assay after direct inoculation of the CAM. The optimal time for inoculation was day 10 of embryo incubation; therafter the log-10 CAM lesions decreased as a negative linear function of embryo age at the time of inoculation. The log-10 CAM lesions increased as a positive linear function of the time since inoculation. The optimal time for counts was day 5 after inoculation. The log-10 CAM lesions was a linear function of the log-10 cells in the inoculum; the slope was 1.0. Venous in ovo inoculation caused as increase in the weight of the spleen proportional to the number of CAM lesions. Repression of the splenomegaly, by prior X irradiation of the embryo, did not reduce the number of CAM lesions. Embryols from lines inbred for susceptibility to Marek's disease produced more CAM lesions than embryos from resistant lines. This difference did not depend on prior exposure of the mothers to MDV or HVT.

Entities:  

Mesh:

Year:  1975        PMID: 164413      PMCID: PMC415159          DOI: 10.1128/iai.11.5.922-931.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Influence of maternal antibody on infection with virulent or attenuated Marek's disease herpesvirus.

Authors:  J L Spencer; A Robertson
Journal:  Am J Vet Res       Date:  1972-02       Impact factor: 1.156

2.  Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance.

Authors:  J L Spencer; A A Grunder; A Robertson; G W Speckmann
Journal:  Avian Dis       Date:  1972-04       Impact factor: 1.577

3.  Lyophilization of cell-free Marek's disease herpesvirus and a herpesvirus from turkeys.

Authors:  B W Calnek; S B Hitchner; H K Adldinger
Journal:  Appl Microbiol       Date:  1970-11

4.  Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus.

Authors:  P S Morahan; S E Grossberg
Journal:  J Infect Dis       Date:  1970-06       Impact factor: 5.226

5.  Age-related cellular resistance of the chicken embryo to viral infections. II. Inducible resistance produced by influenza virus and Escherichia coli.

Authors:  P S Morahan; S E Grossberg
Journal:  J Infect Dis       Date:  1970-06       Impact factor: 5.226

6.  Use of the embryonating egg in studies on Marek's disease.

Authors:  P M Biggs; B S Milne
Journal:  Am J Vet Res       Date:  1971-11       Impact factor: 1.156

7.  Diagnosis and certain biological properties of the virus of Marek's disease.

Authors:  V von Bülow
Journal:  Am J Vet Res       Date:  1971-08       Impact factor: 1.156

8.  Measurement of graft-versus-host reactions on the chorioallantoic membrane of the chicken.

Authors:  B M Longenecker; S Sheridan; G R Law; R F Ruth
Journal:  Transplantation       Date:  1970-06       Impact factor: 4.939

9.  Genetic control of graft-versus-host competence.

Authors:  B M Longenecker; F Pazderka; G R Law; R F Ruth
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

10.  Cell culture techniques for primary isolation of Marek's disease-associated herpesvirus.

Authors:  R L Witter; J J Solomon; G H Burgoyne
Journal:  Avian Dis       Date:  1969-02       Impact factor: 1.577

View more
  1 in total

1.  Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.

Authors:  Xiaojia Wang; Xiaojing Chi; Ming Wang
Journal:  Virol J       Date:  2011-04-25       Impact factor: 4.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.